Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Feb;14(1):40-4.
doi: 10.17305/bjbms.2014.2295.

Influence of Rho kinase inhibitor Fasudil on late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension

Affiliations
Randomized Controlled Trial

Influence of Rho kinase inhibitor Fasudil on late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension

Pei Liu et al. Bosn J Basic Med Sci. 2014 Feb.

Abstract

The objective of our work was to investigate the influence of Fasudil, a Rho inhibitor on the number and function of the late endothelial progenitor cells in peripheral blood of chronic obstructive pulmonary diseases (COPD) patients with pulmonary artery hypertension. Eighty COPD patients with pulmonary artery hypertension were selected and divided into two groups: the treatment group and the control group, which had 40 patients respectively. The control group received routine treatment, including oxygen uptake, anti-infection and phlegm dissolving. The treatment group received the Fasudil in addition to the routine treatment. The changes on the number and function of the late endothelial progenitor cells in peripheral blood of the patients before and after the treatment were compared between the two groups. The changes on the pulmonary artery pressure were also compared. The number of the late endothelial progenitor cells in peripheral blood of the treatment group increased and the function was enhanced. The pulmonary artery pressure was reduced. The difference before and after the treatment and with the control group was statistically significant (p<0.05). The changes on the number and function of the late endothelial progenitor cells in peripheral blood and the pulmonary artery pressure before and after the treatment of the control group were not statistically significant (p>0.05). The Rho-kinase inhibitor Fasudil increased the number and enhanced the function of the late endothelial progenitor cells in peripheral blood of COPD patients with pulmonary artery hypertension.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
The late EPC cultured in isolation was measured for the positivity of cell phenotypes of CD34 and KDR by a flow cytometry.
FIGURE 2
FIGURE 2
The absorption of DiLDL combining with FITC-UEA-I (double positivity)

Similar articles

Cited by

References

    1. Melek M, Esen O, Esen AM, Barutcu I, Fidan F, Onrat E, et al. Tissue Doppler evaluation of tricuspid annulus for estimation of pul-monary artery pressure in patients with COPD. Lung. 2006;184(3):121–131. - PubMed
    1. Yue W S, Wang M, Yan G H, Yiu KH, Yin L, Lee SW, et al. Smoking is associated with depletion of circulating endothelial progenitor cells and elevated pulmonary artery systolic pressure in patients with coronary artery disease. Am J Cardiol. 2010;106(9):1248–1254. - PubMed
    1. Kwon S M, Lee Y K, Yokoyama A, Jung SY, Masuda H, Kawamoto A, et al. Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascu-larization. J Mol Cell Cardiol. 2011;51(3):308–317. - PubMed
    1. Hur J, Yoon C H, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24(2):288–293. - PubMed
    1. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation. 2005;112(11):1618–1627. - PubMed

Publication types

MeSH terms